These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38143937)

  • 1. Allergen-specific immunotherapy and evidence: A European regulatory perspective.
    Bartel D; Bonertz A; Hartenstein D; Kaul S; Lauer I; Reeb C; Rösner-Friese K; Sliva K; Zimmer J; Vieths S; Mahler V
    Allergol Select; 2023; 7():198-210. PubMed ID: 38143937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy of allergies: current status].
    Mahler V; Kleine-Tebbe J; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Nov; 63(11):1341-1356. PubMed ID: 33140209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019.
    Mahler V; Mentzer D; Bonertz A; Muraro A; Eigenmann P; Bousquet J; Halken S; Pfaar O; Jutel M; Wahn U; Vieths S; Kaul S
    Clin Transl Allergy; 2020; 10():28. PubMed ID: 32612805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023.
    Pfaar O; Becker S; Calabria C; Hartenstein D; Jung J; Zimmer J; Ponda P
    World Allergy Organ J; 2023 May; 16(5):100766. PubMed ID: 37251813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
    May S; Kaul S; Schröder C; Vieths S
    Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy.
    Pfaar O; Hamelmann E; Taube C; Wagenmann M; Wedi B; Werfel T; Bartel D; Bonertz A; Hartenstein D; Kaul S; Mahler V; Worm M
    Allergol Select; 2023; 7():229-235. PubMed ID: 38143938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Governmental batch sample testing of allergen products].
    Bartel D; Führer F; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):358-62. PubMed ID: 22373849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
    Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
    World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.
    Rose K; Kopp MV
    Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives in allergen immunotherapy: 2019 and beyond.
    Pfaar O; Agache I; de Blay F; Bonini S; Chaker AM; Durham SR; Gawlik R; Hellings PW; Jutel M; Kleine-Tebbe J; Klimek L; Kopp MV; Nandy A; Rabin RL; van Ree R; Renz H; Roberts G; Salapatek AM; Schmidt-Weber CB; Shamji MH; Sturm GJ; Virchow JC; Wahn U; Willers C; Zieglmayer P; Akdis CA
    Allergy; 2019 Dec; 74 Suppl 108():3-25. PubMed ID: 31872476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers.
    Becker S; Fassio F; Muñoz-Cano R; Klimek L; Vidal C; Heath MD; Kündig TM; Vogelberg C; Toran C; Jensen-Jarolim E; Heffler E; Tomazic PV; Feindor M; Hewings S; Carreno T; Morales M; Mösges R; Skinner MA; Graessel A; Hernandez D; Kramer MF
    J Investig Allergol Clin Immunol; 2022 Oct; 32(5):345-356. PubMed ID: 35522054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products.
    Bonertz A; Roberts GC; Hoefnagel M; Timon M; Slater JE; Rabin RL; Bridgewater J; Pini C; Pfaar O; Akdis C; Goldstein J; Poulsen LK; van Ree R; Rhyner C; Barber D; Palomares O; Sheikh A; Pawankar R; Hamerlijnk D; Klimek L; Agache I; Angier E; Casale T; Fernandez-Rivas M; Halken S; Jutel M; Lau S; Pajno G; Sturm G; Varga EM; Gerth van Wijk R; Bonini S; Muraro A; Vieths S
    Allergy; 2018 Jan; 73(1):64-76. PubMed ID: 28771830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology - ASBAI.
    Aarestrup FM; Taketomi EA; Santos Galvão CE; Gagete E; Nóbrega Machado Arruda AC; Alves GB; Véras de Araújo Gueiros Lira G; Gonçalves MR; Couto Miziara MG; Maranhão Casado SS; Curi SV; Rufino Pereira VA; Sales V; Solé D; de Paula Motta Rubini N; Cavalcanti Sarinho ES
    World Allergy Organ J; 2022 Oct; 15(10):100697. PubMed ID: 36254179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.
    Passalacqua G; Canonica GW; Bagnasco D
    Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany.
    Brehler R; Klimek L; Vogelberg C; Werfel T; Pfaar O; Hamelmann E
    Allergo J Int; 2016; 25():38-43. PubMed ID: 27226950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essentials of allergen immunotherapy: A primer for the practitioner.
    Bellanti JA; Settipane RA; DuBuske L
    Allergy Asthma Proc; 2022 Jul; 43(4):245-247. PubMed ID: 35818156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dogmas, challenges, and promises in phase III allergen immunotherapy studies.
    De Kam PJ; Kramer MF; Shamji MH; Oluwayi K; Heath MD; Jensen-Jarolim E; Berger MH; Berger UE; Graessel A; Sellwood F; Zielen S; Vogelberg C; Zieglmayer P; Mösges R; Klimek L; DuBuske LM; Shreffler WG; Bernstein JA; Kündig TM; Skinner MA
    World Allergy Organ J; 2021 Sep; 14(9):100578. PubMed ID: 34659627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIT in pediatric allergology: Opportunities and difficulties on the home stretch of the Therapy Allergen Ordinance.
    Vogelberg C; Gerstlauer M
    Allergol Select; 2023; 7():236-241. PubMed ID: 38143936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy.
    Englert L; Mahler V; Bonertz A
    Curr Allergy Asthma Rep; 2021 May; 21(5):32. PubMed ID: 33970347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.